Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $436 Million. The most recent transaction as insider was on Feb 23, 2023, when has been sold 40,000 shares (Common Stock) at a price of $0.99 per share, resulting in proceeds of $39,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M
0.49% 3M change
1.39% 12M change
Total Value Held $436 Million

Stephane Bancel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Feb 22 2023
SELL
Open market or private sale
$6,362,800 $159.07 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Feb 22 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Feb 16 2023
SELL
Open market or private sale
$6,923,200 $173.08 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Feb 15 2023
SELL
Open market or private sale
$7,010,400 $175.26 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Feb 09 2023
SELL
Open market or private sale
$6,680,800 $167.02 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Feb 08 2023
SELL
Open market or private sale
$6,686,400 $167.16 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Feb 08 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Feb 02 2023
SELL
Open market or private sale
$6,942,800 $173.57 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Feb 02 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Feb 01 2023
SELL
Open market or private sale
$6,856,000 $171.4 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Jan 26 2023
SELL
Open market or private sale
$7,624,800 $190.62 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Jan 26 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Jan 25 2023
SELL
Open market or private sale
$7,678,800 $191.97 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Jan 25 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Jan 19 2023
SELL
Open market or private sale
$7,694,800 $192.37 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Jan 19 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Jan 18 2023
SELL
Open market or private sale
$8,036,400 $200.91 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Jan 18 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Jan 12 2023
SELL
Open market or private sale
$7,351,600 $183.79 p/Share
40,000 Reduced 0.73%
5,411,946 Common Stock
Jan 12 2023
BUY
Exercise of conversion of derivative security
$39,600 $0.99 p/Share
40,000 Added 0.73%
5,451,946 Common Stock
Stephane Bancel

Stephane Bancel

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA